Gary K Hulse

Summary

Affiliation: University of Western Australia
Country: Australia

Publications

  1. doi request reprint Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone
    Gary K Hulse
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, Western Australia 6009
    Arch Gen Psychiatry 66:1108-15. 2009
  2. pmc Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants
    Gary K Hulse
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, QE II Medical Centre, Nedlands, WA 6009, Australia
    Drug Alcohol Depend 79:351-7. 2005
  3. ncbi request reprint Mental health outcomes following naltrexone implant treatment for heroin-dependence
    Hanh T T Ngo
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, QE II Medical Centre, Nedlands, WA 6009, Australia
    Prog Neuropsychopharmacol Biol Psychiatry 31:605-12. 2007
  4. doi request reprint Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone
    Gary K Hulse
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, Western Australia
    Biol Psychiatry 68:296-302. 2010
  5. doi request reprint Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance
    Hanh T T Ngo
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, WA, Australia
    J Psychopharmacol 25:774-82. 2011
  6. doi request reprint Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation
    Hanh T T Ngo
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, Western Australia, Australia
    Arch Gen Psychiatry 65:457-65. 2008
  7. ncbi request reprint Hospital morbidity associated with the natural history of heroin use
    Robert J Tait
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Nedlands, Western Australia
    J Opioid Manag 4:321-7. 2008
  8. ncbi request reprint Naltrexone implant and blood naltrexone levels over pregnancy
    Gary K Hulse
    Unit for Research and Education in Drugs and Alcohol, School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, Australia
    Aust N Z J Obstet Gynaecol 43:386-8. 2003
  9. ncbi request reprint Emergency department-based intervention with adolescent substance users: 12-month outcomes
    Robert J Tait
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, QEII Campus, Nedlands, WA 6009, Australia
    Drug Alcohol Depend 79:359-63. 2005
  10. ncbi request reprint Biodegradability of naltrexone-poly(DL) lactide implants in vivo assessed under ultrasound in humans
    Gary K Hulse
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Australia
    Addict Biol 13:364-72. 2008

Collaborators

Detail Information

Publications19

  1. doi request reprint Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone
    Gary K Hulse
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, Western Australia 6009
    Arch Gen Psychiatry 66:1108-15. 2009
    ..Oral naltrexone hydrochloride effectively antagonizes heroin, but its utility is limited by patient noncompliance. Sustained-release preparations may overcome this limitation...
  2. pmc Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants
    Gary K Hulse
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, QE II Medical Centre, Nedlands, WA 6009, Australia
    Drug Alcohol Depend 79:351-7. 2005
    ..A sub-group of this cohort (n=146; 83 males) had previously received treatment with oral naltrexone, which also allowed a comparison of overdoses pre- and post-oral and also post-implant treatments...
  3. ncbi request reprint Mental health outcomes following naltrexone implant treatment for heroin-dependence
    Hanh T T Ngo
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, QE II Medical Centre, Nedlands, WA 6009, Australia
    Prog Neuropsychopharmacol Biol Psychiatry 31:605-12. 2007
    ..Oral naltrexone is an approved treatment for opioid dependence. However, the impact of sustained release naltrexone on the mental health of treated opioid users has not been studied...
  4. doi request reprint Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone
    Gary K Hulse
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, Western Australia
    Biol Psychiatry 68:296-302. 2010
    ..Few data are available on optimal blood naltrexone levels for preventing craving and/or return to heroin use. This study assesses various risk factors, including blood naltrexone level, for heroin craving and relapse to illicit opioids...
  5. doi request reprint Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance
    Hanh T T Ngo
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, WA, Australia
    J Psychopharmacol 25:774-82. 2011
    ..Differences in research methodology were noted; recommendation for rigorous analytical methodology in future research on assessing treatment outcomes was accordingly offered...
  6. doi request reprint Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation
    Hanh T T Ngo
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, Western Australia, Australia
    Arch Gen Psychiatry 65:457-65. 2008
    ..To our knowledge, long-term sustainability of changes in patients' drug use and associated hospital morbidity posttreatment have not been studied...
  7. ncbi request reprint Hospital morbidity associated with the natural history of heroin use
    Robert J Tait
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Nedlands, Western Australia
    J Opioid Manag 4:321-7. 2008
    ..To assess changes in hospital morbidity associated with heroin use from pre-initiation, recreational to dependent use, and changes following treatment...
  8. ncbi request reprint Naltrexone implant and blood naltrexone levels over pregnancy
    Gary K Hulse
    Unit for Research and Education in Drugs and Alcohol, School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, Australia
    Aust N Z J Obstet Gynaecol 43:386-8. 2003
  9. ncbi request reprint Emergency department-based intervention with adolescent substance users: 12-month outcomes
    Robert J Tait
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, QEII Campus, Nedlands, WA 6009, Australia
    Drug Alcohol Depend 79:359-63. 2005
    ..In conclusion, while brief intervention in ED only has limited success in facilitating adolescents to attend for subsequent AOD treatment, it can significantly reduce the number of AOD related ED presentations...
  10. ncbi request reprint Biodegradability of naltrexone-poly(DL) lactide implants in vivo assessed under ultrasound in humans
    Gary K Hulse
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Australia
    Addict Biol 13:364-72. 2008
    ..Collectively, these data provide direct evidence of the in vivo absorption of the Go Medical implant over time, and its biodegradability in humans...
  11. doi request reprint Motivation to quit smoking among hospitalised individuals with and without mental health disorders
    Ranita Siru
    University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, Australia
    Aust N Z J Psychiatry 44:640-7. 2010
    ..A decreased level of motivation may partially explain lower cessation rates, but there is little information on motivation among inpatients with MHD...
  12. doi request reprint Smoking is associated with reduced cortical regional gray matter density in brain regions associated with incipient Alzheimer disease
    Osvaldo P Almeida
    Western Australia Centre for Health and Ageing, School of Psychiatry and Clinical Neurosciences, University of Western Australia, 35 Stirling Highway, Perth, Western Australia 6009, Australia
    Am J Geriatr Psychiatry 16:92-8. 2008
    ..The authors designed this study to determine if older people who smoke have decreased gray matter density in brain regions associated with incipient AD...
  13. doi request reprint Assessing motivation to quit smoking in people with mental illness: a review
    Ranita Siru
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, QE II Medical Centre, Nedlands, WA, Australia
    Addiction 104:719-33. 2009
    ..Helping these people to quit smoking is a public health priority; however, many MH professionals assume that those with mental illness are not motivated to quit...
  14. ncbi request reprint Effectiveness of a smoking cessation intervention in older adults
    Robert J Tait
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Australia
    Addiction 102:148-55. 2007
    ....
  15. ncbi request reprint Hospital morbidity and alcohol consumption in less severe psychiatric disorder: 7-year outcomes
    Robert J Tait
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, D Block, QEII Campus, Nedlands, WA 6009
    Br J Psychiatry 188:554-9. 2006
    ..Substance use by people with severe psychiatric morbidity is associated with negative outcomes...
  16. ncbi request reprint Adolescent substance use and hospital presentations: a record linkage assessment of 12-month outcomes
    Robert J Tait
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, QE II Medical Centre, Nedlands, WA 6009, Australia
    Drug Alcohol Depend 79:365-71. 2005
    ....
  17. ncbi request reprint Dementia associated with alcohol and other drug use
    Gary K Hulse
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Australia
    Int Psychogeriatr 17:S109-27. 2005
    ..Health promotion programs designed to decrease tobacco smoking and "harmful" alcohol use (and possibly other drug use) may decrease the burden of cognitive impairment and perhaps dementia in later life...
  18. ncbi request reprint Blood morphine levels in naltrexone-exposed compared to non-naltrexone-exposed fatal heroin overdoses
    Diane E Arnold-Reed
    School of Psychiatry and Clinical Neurosciences, The University of Western Australia, Nedlands, Western Australia
    Addict Biol 8:343-50. 2003
    ..Other drug use in relation to heroin-related fatalities is discussed. Findings do not support the hypothesis that prior exposure to naltrexone increases sensitivity to heroin toxicity...
  19. ncbi request reprint A systematic review of the effectiveness of brief interventions with substance using adolescents by type of drug
    Robert J Tait
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Nedlands, WA 6009, Australia
    Drug Alcohol Rev 22:337-46. 2003
    ..The effect of BI with multiple substances appears substantial but the small sample cautions against expansive generalization...